Cite
HARVARD Citation
Le Tilly, O. et al. (2022). Is CD25 blockade optimal in kidney transplant patients treated with basiliximab? A target‐mediated drug disposition model. British journal of clinical pharmacology. 88 (7), pp. 3500-3505. [Online].